306 related articles for article (PubMed ID: 17990349)
41. The Neuropeptide System and Colorectal Cancer Liver Metastases: Mechanisms and Management.
Kasprzak A; Adamek A
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429087
[TBL] [Abstract][Full Text] [Related]
42. Identification of EMT-related high-risk stage II colorectal cancer and characterisation of metastasis-related genes.
Wang K; Song K; Ma Z; Yao Y; Liu C; Yang J; Xiao H; Zhang J; Zhang Y; Zhao W
Br J Cancer; 2020 Aug; 123(3):410-417. PubMed ID: 32435058
[TBL] [Abstract][Full Text] [Related]
43. Lymphangiogenic Gene Expression Is Associated With Lymph Node Recurrence and Poor Prognosis After Partial Hepatectomy for Colorectal Liver Metastasis.
Vellinga TT; Kranenburg O; Frenkel N; Ubink I; Marvin D; Govaert K; van Schelven S; Hagendoorn J; Borel Rinkes IH
Ann Surg; 2017 Nov; 266(5):765-771. PubMed ID: 28742689
[TBL] [Abstract][Full Text] [Related]
44. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
[TBL] [Abstract][Full Text] [Related]
45. A novel long non-coding RNA lnc-GNAT1-1 is low expressed in colorectal cancer and acts as a tumor suppressor through regulating RKIP-NF-κB-Snail circuit.
Ye C; Shen Z; Wang B; Li Y; Li T; Yang Y; Jiang K; Ye Y; Wang S
J Exp Clin Cancer Res; 2016 Dec; 35(1):187. PubMed ID: 27912775
[TBL] [Abstract][Full Text] [Related]
46. A Comprehensive MicroRNA Expression Profile of Liver and Lung Metastases of Colorectal Cancer with Their Corresponding Host Tissue and Its Prognostic Impact on Survival.
Pecqueux M; Liebetrau I; Werft W; Dienemann H; Muley T; Pfannschmidt J; Müssle B; Rahbari N; Schölch S; Büchler MW; Weitz J; Reissfelder C; Kahlert C
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775664
[TBL] [Abstract][Full Text] [Related]
47. Identification of microRNA 885-5p as a novel regulator of tumor metastasis by targeting CPEB2 in colorectal cancer.
Lam CS; Ng L; Chow AK; Wan TM; Yau S; Cheng NS; Wong SK; Man JH; Lo OS; Foo DC; Poon JT; Pang RW; Law WL
Oncotarget; 2017 Apr; 8(16):26858-26870. PubMed ID: 28460469
[TBL] [Abstract][Full Text] [Related]
48. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR.
Li W; Chang J; Wang S; Liu X; Peng J; Huang D; Sun M; Chen Z; Zhang W; Guo W; Li J
Oncotarget; 2015 Sep; 6(27):24448-62. PubMed ID: 26259252
[TBL] [Abstract][Full Text] [Related]
49. Integrative genomic and transcriptomic characterization of matched primary and metastatic liver and colorectal carcinoma.
Roessler S; Lin G; Forgues M; Budhu A; Hoover S; Simpson RM; Wu X; He P; Qin LX; Tang ZY; Ye QH; Wang XW
Int J Biol Sci; 2015; 11(1):88-98. PubMed ID: 25552933
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.
Li J; Chen Y; Guo X; Zhou L; Jia Z; Tang Y; Lin L; Liu W; Ren C
Tumour Biol; 2016 Jul; 37(7):8765-73. PubMed ID: 26743779
[TBL] [Abstract][Full Text] [Related]
51. New Wnt/β-catenin target genes promote experimental metastasis and migration of colorectal cancer cells through different signals.
Qi J; Yu Y; Akilli Öztürk Ö; Holland JD; Besser D; Fritzmann J; Wulf-Goldenberg A; Eckert K; Fichtner I; Birchmeier W
Gut; 2016 Oct; 65(10):1690-701. PubMed ID: 26156959
[TBL] [Abstract][Full Text] [Related]
52. Epigenetic suppression of E-cadherin expression by Snail2 during the metastasis of colorectal cancer.
Hu Y; Dai M; Zheng Y; Wu J; Yu B; Zhang H; Kong W; Wu H; Yu X
Clin Epigenetics; 2018 Dec; 10(1):154. PubMed ID: 30541610
[TBL] [Abstract][Full Text] [Related]
53. Differential CXC receptor expression in colorectal carcinomas.
Rubie C; Kollmar O; Frick VO; Wagner M; Brittner B; Gräber S; Schilling MK
Scand J Immunol; 2008 Dec; 68(6):635-44. PubMed ID: 18959627
[TBL] [Abstract][Full Text] [Related]
54. Molecular and Immunohistochemical Markers with Prognostic and Predictive Significance in Liver Metastases from Colorectal Carcinoma.
Lopez G; Boggio F; Ferrero S; Fusco N; Del Gobbo A
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30282914
[TBL] [Abstract][Full Text] [Related]
55. [Prognostic biomarkers for metastatic colorectal cancer].
Neumann JH
Pathologe; 2016 Nov; 37(Suppl 2):180-185. PubMed ID: 27638531
[TBL] [Abstract][Full Text] [Related]
56. Prognostic microRNA expression signature from examination of colorectal primary and metastatic tumors.
Ellermeier C; Vang S; Cleveland K; Durand W; Resnick MB; Brodsky AS
Anticancer Res; 2014 Aug; 34(8):3957-67. PubMed ID: 25075017
[TBL] [Abstract][Full Text] [Related]
57. Expression profiling and interferon-beta regulation of liver metastases in colorectal cancer cells.
Zimmer R; Thomas P
Clin Exp Metastasis; 2002; 19(6):541-50. PubMed ID: 12405292
[TBL] [Abstract][Full Text] [Related]
58. A five-gene signature as a potential predictor of metastasis and survival in colorectal cancer.
Hao JM; Chen JZ; Sui HM; Si-Ma XQ; Li GQ; Liu C; Li JL; Ding YQ; Li JM
J Pathol; 2010 Mar; 220(4):475-89. PubMed ID: 20077526
[TBL] [Abstract][Full Text] [Related]
59. Invasion front-specific expression and prognostic significance of microRNA in colorectal liver metastases.
Kahlert C; Klupp F; Brand K; Lasitschka F; Diederichs S; Kirchberg J; Rahbari N; Dutta S; Bork U; Fritzmann J; Reissfelder C; Koch M; Weitz J
Cancer Sci; 2011 Oct; 102(10):1799-807. PubMed ID: 21722265
[TBL] [Abstract][Full Text] [Related]
60. Disruption of clock gene expression in human colorectal liver metastases.
Huisman SA; Ahmadi AR; IJzermans JN; Verhoef C; van der Horst GT; de Bruin RW
Tumour Biol; 2016 Oct; 37(10):13973-13981. PubMed ID: 27492458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]